CSI Market
Sign In | Register

Myovant Sciences Ltd (MYOV) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MYOV Annual Cash Flow →
This page allows investors to follow Myovant Sciences Ltd's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
9 Months 		(Sep 30 2022) (Jun 30 2022) (Mar 31 2022) (Dec 31 2021)
Operating Activities
Income-124.49
Depreciation & amortization1.01
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-9.03
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-21.79
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation32.40
Income (Loss) from Equity Method Investments0.00
Foreign Currency Transaction Gain (Loss), before Tax, Total0.00
Increase Decreasein Interest Payable Net Current-
Depreciation and Amortization Excluding Amortization of Debt Issuance Costs and Discounts-
Increase Decrease In Accrued Liabilities Collaboration Agreement Current-6.80
Increase Decrease In Collaborative Arrangement Liability-34.39
Increase Decrease In Due From Collaborators-
Interest Expense Noncash0.57
Increase Decrease In Interest Payable Related Party Net Current-
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable-2.42
Accounts Payable0.08
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities18.74
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-15.55
Other Working Capital9.74
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-17.87
Discontinued operations0.00
Net Cash flow from Operating Activities-169.78
Investing Activities
Capital Expenditures-0.61
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities-24.86
Real Estate Investments0.00
Proceeds From Maturities Prepayments And Calls Of Marketable Securities28.50
Proceeds From Sale Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities3.02
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock6.71
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Offering Costs Incurred But Not Yet Paid-
Noncash Or Part Noncash Acquisition Value Of Assets Acquired-
Repayments Of Amounts Due To Related Party For Amounts Paid On Behalf Of Entity-
Proceeds From Settlement of Common Shares Subscribed-
Financing and Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction-
Payments of Debt Administrative Fees-
Noncash Proceeds from Stock Option Exercises-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Stock Issuance Costs Incurred During Noncashor Partial Noncash Transaction-
Noncashor Part Noncash Transaction Warrants Issued-
Proceeds from Debt Net of Issuance Costs Excluding Related Party Debt-
Interest Paid Excluding Capitalized Interest Operating Activities Excluding Related Parties-
Interest Paid Excluding Capitalized Interest Operating Activities Related Parties-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities6.71
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-170.40
Total Cash Flow-160.05
4 historic quarters locked

Sign in to unlock the full Myovant Sciences Ltd cash flow history.

Sign In Create Free Account

About Myovant Sciences Ltd Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001679082-23-000025

Figures are derived from filed reports and may be restated. Historical data is subject to revision.